Lenticulostriate Vasculopathy and Neurodevelopmental Outcomes in Preterm Infants: A Systematic Review

Abby Robinson1, John Flibotte2,3, Summer L Kaplan4

  • 1Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Insights

This systematic review found conflicting evidence on neurodevelopmental outcomes for preterm infants with lenticulostriate vasculopathy (LSV). More research is needed to understand the implications of LSV for these vulnerable infants.

Area of Science:

  • Neonatal neurology
  • Developmental pediatrics

Background:

  • Lenticulostriate vasculopathy (LSV) is a finding on cranial ultrasound in preterm infants.
  • Neurodevelopmental outcomes in this population are not well-established.

Purpose of the Study:

  • To systematically review neurodevelopmental outcomes at 12 months' corrected age or later in preterm infants (< 32 weeks) diagnosed with LSV.
  • To assess the current evidence regarding the impact of LSV on neurodevelopment.

Main Methods:

  • Systematic review of published studies.
  • Inclusion criteria: preterm infants (< 32 weeks) with LSV, neurodevelopmental outcomes at ≥12 months corrected age.
  • Data extraction on neurodevelopmental assessments.

Main Results:

  • Only 3 studies met eligibility criteria, including 44 preterm infants with LSV.
  • Reported neurodevelopmental outcomes were mixed, with some studies indicating mental or motor impairments, and others reporting mild to moderate developmental delay.
  • Conflicting and inconclusive findings across the included studies.

Conclusions:

  • Current evidence on neurodevelopmental implications of LSV in preterm infants is limited and conflicting.
  • There is insufficient data to reliably counsel parents about potential outcomes.
  • Further high-quality research is necessary to clarify the neurodevelopmental trajectory of preterm infants with LSV.

Related Concept Videos